Please assess the completion status of the following clinical trial:

Trial Title: Gene Regulation by Thiazolidinediones

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Capable of giving informed consent~* Agrees to use a barrier method of birth control for the duration of the study~Exclusion Criteria:~* History of inflammatory bowel disease~* Has taken prescription or over the counter medications in the two weeks prior to enrollment~* History of diabetes, heart failure, angina, hypertension, coronary heart disease, cancer, bleeding disorder, HIV, AIDS~* Fasting LDL \>160 mg/dl~* History of smoking in the year prior to enrollment~* Pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Rosiglitazone (Type: OTHER): Rosiglitazone; 8mg tablet once a day for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).